apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Cafirate 20mg Injection 1ml
  3. Cafirate 20mg Injection 1ml Substitute

Cafirate 20mg Injection 1ml Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Uses:

Cafirate 20mg Injection 1ml is commonly used to<br/> 1. Treat prematurity apnea:<br/>Caffeine citrate is most commonly used to treat premature infants, particularly those born preterm. Premature babies, particularly those born before 28 weeks of gestation, may experience pauses in breathing lasting more than 20 seconds (apnea). This is known as apnea of prematurity, and caffeine citrate is used to stimulate the respiratory centre in the brain, hence improving breathing and decreasing apnea episodes.<br/>2. Respiratory stimulation:<br/>Cafirate 20mg Injection 1ml works as a central respiratory stimulant, which means it can be beneficial in instances when respiratory function is limited, particularly in preterm infants with underdeveloped respiratory systems.<br/>3. Improvement of Diuresis:<br/>Caffeine is a moderate diuretic, but this is not the primary reason for its usage in therapeutic settings.<br/>4. Treatment for Neonatal Respiratory Depression:<br/>Caffeine citrate may be utilised in newborns with respiratory depression, particularly when it is associated with disorders such as hypoxia or birth asphyxia.

Medicinal Benefits:

Cafirate 20mg Injection 1ml contains Caffeine Citrate as an active ingredient, which belongs to the central nervous system (CNS) stimulants class. By activating the respiratory centre and making it more sensitive to hypercapnia, this medication helps control the mean respiratory rate and tidal volume and enhances pulmonary blood flow.

FAQs

Cafirate 20mg Injection 1ml is used in the treatment of apnea of premature newborns.

Cafirate 20mg Injection 1ml contains 'Caffeine Citrate', which belongs to the central nervous system (CNS) stimulants class. This medicine stimulates the respiratory center, sensitizing it to hypercapnia. Thereby Cafirate 20mg Injection 1ml effectively regulates the mean respiratory rate and tidal volume, improves pulmonary blood flow, and enhances the breathing pattern.

No, it is intended to treat apnea in premature newborns and neonates.

The dosage is determined by your babys weight, medical problems, and responsiveness to therapy. Before determining the dose, it is also necessary to establish the baseline serum caffeine levels in children born to caffeine-consuming mothers.